Centessa Pharmaceuticals (CNTA) Short-term Investments: 2023-2025
Historic Short-term Investments for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Sep 2025 value amounting to $195.4 million.
- Centessa Pharmaceuticals' Short-term Investments rose 58.32% to $195.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $195.4 million, marking a year-over-year increase of 58.32%. This contributed to the annual value of $99.0 million for FY2024, which is 23.00% down from last year.
- Per Centessa Pharmaceuticals' latest filing, its Short-term Investments stood at $195.4 million for Q3 2025, which was down 5.37% from $206.5 million recorded in Q2 2025.
- In the past 5 years, Centessa Pharmaceuticals' Short-term Investments registered a high of $206.5 million during Q2 2025, and its lowest value of $86.2 million during Q1 2023.
- In the last 3 years, Centessa Pharmaceuticals' Short-term Investments had a median value of $128.5 million in 2023 and averaged $142.4 million.
- As far as peak fluctuations go, Centessa Pharmaceuticals' Short-term Investments dropped by 23.00% in 2024, and later surged by 60.19% in 2025.
- Over the past 3 years, Centessa Pharmaceuticals' Short-term Investments (Quarterly) stood at $128.5 million in 2023, then dropped by 23.00% to $99.0 million in 2024, then soared by 58.32% to $195.4 million in 2025.
- Its Short-term Investments was $195.4 million in Q3 2025, compared to $206.5 million in Q2 2025 and $179.3 million in Q1 2025.